Drug metabolism in the liver
OA Almazroo, MK Miah… - Clinics in liver …, 2017 - liver.theclinics.com
Drugs are typically small molecules that are generally classified as xenobiotics, which are
foreign to the human body. Several endogenous molecules, however, such as steroids and …
foreign to the human body. Several endogenous molecules, however, such as steroids and …
Sex-and gender-based pharmacological response to drugs
In humans, the combination of all sex-specific genetic, epigenetic, and hormonal influences
of biologic sex produces different in vivo environments for male and female cells. We dissect …
of biologic sex produces different in vivo environments for male and female cells. We dissect …
Use of Medication for Cardiovascular Disease During Pregnancy: JACC State-of-the-Art Review
DG Halpern, CR Weinberg, R Pinnelas… - Journal of the American …, 2019 - jacc.org
Cardiovascular disease complicating pregnancy is rising in prevalence secondary to
advanced maternal age, cardiovascular risk factors, and the successful management of …
advanced maternal age, cardiovascular risk factors, and the successful management of …
Anatomical and physiological alterations of pregnancy
The extensive metabolic demands of pregnancy require specific physiological and
anatomical changes. These changes affect almost all organ systems, including the …
anatomical changes. These changes affect almost all organ systems, including the …
British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids
MD Russell, M Dey, J Flint, P Davie, A Allen… - …, 2023 - academic.oup.com
Background The rationale behind this update of the 2016 British Society for Rheumatology
(BSR) guidelines on prescribing anti-rheumatic drugs in pregnancy and breastfeeding [1, 2] …
(BSR) guidelines on prescribing anti-rheumatic drugs in pregnancy and breastfeeding [1, 2] …
Sex and gender differences in Alzheimer's disease: current challenges and implications for clinical practice: position paper of the Dementia and Cognitive Disorders …
MT Ferretti, J Martinkova, E Biskup… - European journal of …, 2020 - Wiley Online Library
Alzheimer's disease (AD) is characterized by high heterogeneity in disease manifestation,
progression and risk factors. High phenotypic variability is currently regarded as one of the …
progression and risk factors. High phenotypic variability is currently regarded as one of the …
An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus
LW Han, C Gao, Q Mao - Expert opinion on drug metabolism & …, 2018 - Taylor & Francis
ABSTRACT Introduction: P-glycoprotein (P-gp)/ABCB1 and breast cancer resistance protein
(BCRP)/ABCG2 are highly expressed in the placenta and fetus throughout gestation and …
(BCRP)/ABCG2 are highly expressed in the placenta and fetus throughout gestation and …
Long-acting antiretrovirals and HIV treatment adherence
JB Nachega, KK Scarsi, M Gandhi, RK Scott… - The Lancet …, 2023 - thelancet.com
Intramuscular injection of long-acting cabotegravir and rilpivirine is a novel, long-acting
antiretroviral therapy (ART) combination approved for use as a fully suppressive regimen for …
antiretroviral therapy (ART) combination approved for use as a fully suppressive regimen for …
2023 HRS expert consensus statement on the management of arrhythmias during pregnancy
This international multidisciplinary expert consensus statement is intended to provide
comprehensive guidance that can be referenced at the point of care to cardiac …
comprehensive guidance that can be referenced at the point of care to cardiac …
The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo
DA Sychev, GM Ashraf, AA Svistunov… - Drug design …, 2018 - Taylor & Francis
Cytochrome (CYP) 450 isoenzymes are the basic enzymes involved in Phase I
biotransformation. The most important role in biotransformation belongs to CYP3A4 …
biotransformation. The most important role in biotransformation belongs to CYP3A4 …